Penn State’s 3D Printed CaroFlex Device Opens a New Front in Drug-Resistant Hypertension
3D Printing Industry
AI SUMMARY
Penn State University researchers have developed a 3D printed bioelectronic device called CaroFlex to treat drug-resistant hypertension, a condition affecting roughly 10% of the 50 million Americans with high blood pressure. The soft, implantable device represents an advancement in additive manufacturing technology applied to medical applications.
FROM THE ARTICLE
Nearly half of all adults in the United States live with hypertension, and for roughly one in ten of them, conventional drug treatments simply don’t work. A research team at Pennsylvania State University (PSU) has developed a potential answer: a soft, 3D printed bioelectronic device that…
This story was originally published by 3D Printing Industry.
Read Full Story on 3D Printing IndustryRelated Stories
3D Printing & PrefabNavy Fast-Tracks 3D Printed Parts to Boost Submarine Production3D Printing IndustryDrones & RoboticsVertico Installs Largest 3D Concrete Printing System to Date at Portuguese Precast Facility3D Printing Industry3D Printing & PrefabSYZMIK’s X7C+ Cuts Concussion Risk 77% With 3D Printed Lattice Padding3D Printing Industry3D Printing & PrefabOnkos Surgical’s 3D printed My3D pelvic platform crosses 1,000 surgical cases3D Printing Industry